In the present study, aucubin demonstrated protective effects against IBD in mice by upregulating antioxidant enzyme activities (e.g., SOD, GSH-Px, CAT), reducing MDA levels, and alleviating oxidative damage. The gene discussed is SOD1; the disease is inflammatory bowel disease.